Analogic Corporation

Analogic — Jefferies 2017 Healthcare Conference

36 slides from Analogic's conference presentation, Jun 7, 2017

  1. Slide 1: Jefferies 2017 Healthcare Conference

    50 Jefferies 2017 Healthcare Conference Mark Frost, SVP and Cfo June 8, 2017 years of imaging innovation Exhibit 99.1

  2. Slide 2: Safe Harbor

    Safe Harbor Any statements about future expectations, plans, and prospects for the Company, including statements containing the words “believes,” “anticipates,” “plans,” “expects,” and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation

  3. Slide 3: Use of Non-GAAP Financial Measures

    This presentation includes non-GAAP financial measures that are not in accordance with, nor an alternative to, generally accepted accounting principles and may be different from such non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive se

  4. Slide 4: Years of Imaging Innovation

    50 Years of Imaging Innovation Founded in 1967 Advancing image guidance technology for medical and security Global research, engineering, and operations Fiscal 2016 Highlights: $509 million revenue $3.54 Non-GAAP* EPS Operating cash of $33 million, Free cash flow** of $20 million 1,500 employees wor

  5. Slide 5: Our Imaging Technology Drives Innovative Products

    Our Imaging Technology Drives Innovative Products Material Science Signal and image processing Precision A/D conversion Precision RF/Power Amplification Imaging & Guidance “Core Technologies” “Critical Imaging Chain” Mammo Ultrasound Probes High voltage power supplies High power amplifiers Pulsed RF

  6. Slide 6: Our Business Segments

    Our Business Segments Medical Imaging Ultrasound Security & Detection 57% of revenues* 32% of revenues* 11% of revenues* Increase content with OEMs Leverage common platforms Drive growth in emerging markets Focus in Urology and Surgery Expand into General Imaging with technology partner Exploit oppo

  7. Slide 7: Moving to the Next Level of Performance

    Moving to the Next Level of Performance Non-GAAP operating margin and non-GAAP EPS figures exclude certain charges; please refer to the non-GAAP reconciliation table in the back of this presentation. Inconsistent results in recent years requires renewed focus

  8. Slide 8: Ultrasound

    ULTRASOUND

  9. Slide 9: Focused Ultrasound Market Opportunities

    Focused Ultrasound Market Opportunities Global Ultrasound Market 2016 ($6.2 billion) 1 POC – Point of care 2 EMED: Emergency Medicine Revenue Growth Rate by Application (’15-’20) BK Ultrasound Markets ($700M) Partner Markets ($3B) Source: IHS May 2017 Technology Partnerships Focused Approach Served

  10. Slide 10: Ultrasound Portfolio Optimization

    Ultrasound Portfolio Optimization Surgical Guidance bk5000 Urology bk3000 General Imaging Partnerships Point of Care Anesthesia/EMED bk3500 Upside opportunities

  11. Slide 11: Ultrasound: Turnaround Opportunity

    Ultrasound: Turnaround Opportunity Sales growth has not matched our pace of investment Focus on optimizing portfolio and improving operating profit in FY18 and future Balance sheet clean-up actions resulting in non-cash charges FY17 estimates are based on mid-point of range Non-GAAP operating margin

  12. Slide 12: Medical Imaging

    Medical Imaging

  13. Slide 13: Guidance in Medical Imaging

    Guidance in Medical Imaging Computed Tomography Digital Mammography Magnetic Resonance

  14. Slide 14: Increasing Value with Full Systems

    Increasing Value with Full Systems Data Acquisition Subsystem Detection Management Subsystem Power & Data Management CT Imaging engine Image Reconfiguration GE OPTIMA NM/CT 640 Accuray TomoTherapy Anke 16-Slice CT

  15. Slide 15: Ruggedized CT Gantry Progressing

    Qinghai Xinjiang Inner Mongolia Tibet Guizhou Zhejiang Fujian Gansu Ningxia Shanxi Shanxi Hebei Heilongjiang Jilin Liaoning Shandong Jiangsu Henan Anhui Hubei Hunan Jiangxi Yunnan Sichuan Chongqing Guangxi Guangdong Ruggedized CT Gantry Progressing Beijing > 185 systems installed

  16. Slide 16: Magnetic Resonance Power Sub-systems

    Magnetic Resonance Power Sub-systems RF Amplifier Gradient Amplifier Enabled 3T wide bore systems Common platforms and modular design Design wins with new market entrants

  17. Slide 17: Digital Mammography Detector Sub-Systems

    Digital Mammography Detector Sub-Systems Analogic Enables Best Detection Superior Se Based Technology Premium 3D tomo performance Lower dose with best image quality Fastest Image acquisition US installed base of 2D is ~ 11,000 systems, more than 5000 are 7+ years Replacement cycle is moving to 3D

  18. Slide 18: Medical Imaging: Solid Profitability

    Medical Imaging: Solid Profitability OEM sourcing decisions effect short term revenue growth in FY17 and FY18 Margin improvement driven by product/customer mix and cost initiatives FY17 estimates are based on mid-point of range Non-GAAP operating margin and non-GAAP EPS figures exclude certain charg

  19. Slide 19: Security and Detection

    Security and Detection

  20. Slide 20: Checked Baggage Opportunities with Leading OEMs

    Checked Baggage Opportunities with Leading OEMs North America Replacement Demand 1800 sockets TSA extended EDS life from 10 to 15 years to prepare for next gen purchases Canada completing purchases of high-speed EDS systems Europe and Middle East Increasing Momentum 2000 sockets Early adoption under

  21. Slide 21: Checkpoint CT Under Evaluation

    Checkpoint CT Under Evaluation ConnectCT accepted into TSA laboratory for formal certification testing; International certification testing in early 2017 Commercial trials with CT in Europe validated a 2X operational improvement with over 1.3 million bags scanned while improving detection ConnectCT

  22. Slide 22: Upside in Rapid DNA

    Upside in Rapid DNA DNA profile generated in under 84 minutes vs. weeks in federal labs Significant market opportunity for law enforcement and government agencies FBI NDIS (National DNA Index System) approval achieved for domestic 4-color version Evaluation currently underway for new global standard

  23. Slide 23: Security and Detection: Strong Op. Leverage

    Security and Detection: Strong Op. Leverage Revenue growth driven by international high speed tenders and upside with Checkpoint CT and RapidDNA FY17 estimates are based on mid-point of range Non-GAAP operating margin and non-GAAP EPS figures exclude certain charges; please refer to the non-GAAP rec

  24. Slide 24: Financial Outlook

    F SIPINANCIAL =. OUTLOOK

  25. Slide 25: Financial Outlook

    Financial Outlook Fiscal 2017 - Expect low to mid-single digit revenue declines with non-GAAP operating margin between 8.5% and 9.5% resulting in non-GAAP diluted EPS of between $2.40 and $2.70 FY17 estimates are based on mid-point of range Non-GAAP operating margin and non-GAAP EPS figures exclude

  26. Slide 26: Strong Balance Sheet and Consistent Cash Flows

    Strong Balance Sheet and Consistent Cash Flows 1 As of July 31, 2015 Includes $12MM tax refund $159M1 of cash/investments with no long term debt - YTD operating cash flow of $54M, Free cash flow of $46M Capital allocation through ongoing investment, M&A and share re-purchase $15 million share repurc

  27. Slide 27: Strategic Options for Improved Value Creation

    Strategic Options for Improved Value Creation Board of Directors has directed that all strategic options be considered to accelerate the pace of value creation for our shareholders Update to these options, as well as an update to FY18 guidance, will be given on or before the Q4 FY17 earnings call 1

  28. Slide 28: Thank You

    Thank You OVERVIEW

  29. Slide 29: Appendix

    Appendix OVERVIEW

  30. Slide 30: Q3 FY17 Financial Highlights

    Q3 FY17 Financial Highlights Revenue and Profitability In-Line * Non-GAAP operating margin/income figures exclude certain charges; please refer to the non-GAAP reconciliation table in the back of this presentation and in Analogic’s Q3 FY 2017 earnings release available at http://investor.analogic.co

  31. Slide 31: Revenue and Non-GAAP Operating Margin Trend

    FY16 FY17 Revenue $M and Non-GAAP* Operating Margin Trend Non-GAAP Operating Margin* Non-GAAP OM 16% 21% 18% 20% 12% 20% 21% GAAP OM 10% 16% 14% 17% 10% 17% 18% 10% 9% 19% 16% 18% 15% 17% 2% -2% 14% 11% 17% 9% 14% FY17 FY16 -5% 7% -5% 4% -11% -2% -14% -13% -23% -13% -2% -16% -11% -228% Q3 FY17 Opera

  32. Slide 32: Working Capital and Cash Flow

    Working Capital and Cash Flow (Amounts may not foot due to rounding to millions) Operating cash flow of $13M in Q3, Cap Ex at $2M resulting in Free cash flow of $11M YTD operating cash flow of $53M and Free cash flow of $46M Accounts receivables up sequentially on timing of shipments Inventory flat

  33. Slide 33: FY 2017 Outlook

    FY 2017 Outlook FY17 – Expect mid-single digit revenue declines with non-GAAP operating margin between 8.5% - 9.5%; non-GAAP diluted EPS of between $2.40 and $2.70 Ultrasound: High-single digits revenue declines with negative low double digit op margin Restructuring actions will disrupt FY17 with lo

  34. Slide 34: Non-GAAP Reconciliation

    Non-Gaap Reconciliation Gi \ OVERVIEW analogic” ‘

  35. Slide 35: Non-GAAP Statements of Operations Reconciliation

    NON-GAAP ST’ ME (hn thousands, excopt per share data) GAAP Income From Operation: Rost ‘Acquistion rolated revenues and expenses Non-GAAP Income From Operations Percentage of Total Net Revenue GAAP Other income (Expen: don BK Medical distrbutor mattor inquiry related costs ‘Acquisition rolated reven

  36. Slide 36: Non-GAAP Statements of Operations Reconciliation

    NON-GAAP STATEMENTS OF OPERATIONS RECONCILIATION (h thousands, except per share data) ‘Twelve months Ended July 34,2012 July 34,2013 July 31,2014 July 31,2015 July31, 2016 Medical Imaging GAAP Income From Operations Shore sation expense “ax refund related cha GAAP Income From Operations " Percentage

Analogic — Jefferies 2017 Healthcare Conference on 6ix